This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • XELJANZ XR
  • /
  • Tofacitinib In Psoriatic Arthritis Subjects With I...
Clinical trial

Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors (OPAL BEYOND)

Read time: 3 mins
Last updated:1st Aug 2013
Identifier: NCT01882439
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest